<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.arubasciencewire.com/article/910458835-latest-findings-from-dme-aware-delphi-study-presented-at-arvo-2026-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T08:00:00+00:00</news:publication_date>
        <news:title>Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/dc25de9c-07c8-448a-b6af-aea02249e593/medium/global-consensus-on-early-intervention-in-dme.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910458853-ecca-and-ttec-release-visionary-voices-research-on-the-future-of-contact-centre-sales-in-europe</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T08:00:00+00:00</news:publication_date>
        <news:title>ECCA and TTEC Release “Visionary Voices” Research on the Future of Contact Centre Sales in Europe</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8488146d-993c-40c8-8d4c-b993aa023cb2/small/screenshot-2025-10-17-132937-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910458857-spec-releases-the-spec-cpu-2026-benchmark-suites-to-address-the-latest-advances-in-cpu-memory-and-compiler-technology</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T08:00:00+00:00</news:publication_date>
        <news:title>SPEC Releases the SPEC CPU 2026 Benchmark Suites to Address the Latest Advances in CPU, Memory, and Compiler Technology </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f6b299a2-9328-4f49-a915-406713f6443f/medium/cpu.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910458841-virtune-ab-publ-virtune-has-completed-the-monthly-rebalancing-for-april-2026-of-its-virtune-crypto-top-10-index-etp-the-first-crypto-index-etp</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T07:56:11+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) (&quot;Virtune&quot;) has completed the monthly rebalancing for April 2026 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910458908-virtune-ab-publ-virtune-har-genomf-rt-den-m-natliga-rebalanseringen-f-r-april-2026-av-virtune-crypto-top-10-index-etp-nordens-f-rsta</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T07:56:11+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för april 2026 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910448866-newhydrogen-drives-toward-commercial-success</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T07:01:00+00:00</news:publication_date>
        <news:title>NewHydrogen Drives Toward Commercial Success</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a8022b5b-f0f7-416d-baf4-953e4db35884/small/newhydrogen-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910448817-cytospire-therapeutics-announces-oversubscribed-61-million-83m-series-a-financing-to-advance-pipeline-of-first-in-class-pan-gamma-delta-t-cell</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T07:00:00+00:00</news:publication_date>
        <news:title>Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/99e8d7e3-84e7-41a5-84aa-4f03dcb8e2be/medium/natalie-mount.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910448852-gauth-expands-across-southeast-asia-with-rollout-of-live-tutor-ai-learning-feature</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T07:00:00+00:00</news:publication_date>
        <news:title>Gauth Expands Across Southeast Asia With Rollout of Live Tutor AI Learning Feature</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/24dc62df-03f6-45e4-96e2-5f67d96b35c9/medium/gauth-live-tutor.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910448853-gauth-berekspansi-ke-asia-tenggara-melalui-peluncuran-fitur-belajar-dengan-live-tutor-berteknologi-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T07:00:00+00:00</news:publication_date>
        <news:title>Gauth Berekspansi ke Asia Tenggara Melalui Peluncuran Fitur Belajar dengan Live Tutor Berteknologi AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/9c01f10f-a4fd-41a7-81bc-8aa8d4b93ef1/image4.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910448859-gauth-meluaskan-kehadiran-di-asia-tenggara-melalui-pelancaran-ciri-pembelajaran-ai-live-tutor</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T07:00:00+00:00</news:publication_date>
        <news:title>GAUTH Meluaskan Kehadiran di Asia Tenggara Melalui Pelancaran Ciri Pembelajaran AI Live Tutor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/32502339-11e9-420b-af9e-5645afb77262/image4.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910448861-gauth-live-tutor-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T07:00:00+00:00</news:publication_date>
        <news:title>Gauth ขยายธุรกิจทั่วเอเชียตะวันออกเฉียงใต้ เปิดตัวฟีเจอร์ Live Tutor การเรียนรู้ที่ใช้ AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/2e119eae-5bcc-4f9b-882f-ea97c6d89a2b/image4.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910448864-gauth-m-r-ng-t-i-ng-nam-v-i-vi-c-tri-n-khai-t-nh-n-ng-h-c-t-p-ai-live-tutor</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T07:00:00+00:00</news:publication_date>
        <news:title>Gauth Mở Rộng Tại Đông Nam Á Với Việc Triển Khai Tính Năng Học Tập AI Live Tutor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/05d732ea-2b15-444a-82bc-3bbd2b1c4729/image4.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910448874-sparc-ai-hires-senergy-communication-capital</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T06:49:11+00:00</news:publication_date>
        <news:title>SPARC AI Hires Senergy Communication Capital</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/63c144a0-5c1d-45ef-99bc-e677d522fbb0/small/sparc-ai-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910448845-novonesis-delivered-strong-start-to-the-year-with-7-organic-sales-growth-in-q1</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T06:18:16+00:00</news:publication_date>
        <news:title>Novonesis delivered strong start to the year with 7% organic sales growth in Q1</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/d0c3bcb0-65ab-400f-9219-15fbf4253148/small/novonesis-logo-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910439198-abivax-announces-repurchase-of-royalty-certificates-and-pricing-of-45m-38-5m-offering-of-american-depositary-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T06:00:00+00:00</news:publication_date>
        <news:title>Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910439216-kinetic-deploys-fiber-optic-network-for-a-more-reliable-digital-future</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T05:21:08+00:00</news:publication_date>
        <news:title>Kinetic Deploys Fiber-Optic Network for a More Reliable Digital Future</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YTk3YjM5OTktMmNkNC00OWFjLWE1OGYtZTJiZWYxMmQ3NjIyLTUwMDE2MjEyNC0yMDI2LTA1LTA1LWVu/tiny/Kinetic.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910429701-santhera-ver-ffentlicht-einladung-zur-ordentlichen-generalversammlung</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T05:00:00+00:00</news:publication_date>
        <news:title>Santhera veröffentlicht Einladung zur ordentlichen Generalversammlung</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910429709-santhera-publishes-agenda-for-its-annual-general-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T05:00:00+00:00</news:publication_date>
        <news:title>Santhera Publishes Agenda for its Annual General Meeting </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910410583-gauth-launches-live-tutor-in-vietnam-expanding-access-to-personalized-ai-learning-support</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T03:00:00+00:00</news:publication_date>
        <news:title>Gauth Launches Live Tutor in Vietnam, Expanding Access to Personalized AI Learning Support</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e59917c4-2978-4e18-b33e-f4d600b4a967/medium/gauth-live-tutor.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910410585-gauth-ra-m-t-t-nh-n-ng-live-tutor-t-i-vi-t-nam-m-r-ng-kh-n-ng-ti-p-c-n-h-tr-h-c-t-p-ai-c-nh-n-h-a</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T03:00:00+00:00</news:publication_date>
        <news:title>Gauth Ra Mắt Tính Năng Live Tutor Tại Việt Nam, Mở Rộng Khả Năng Tiếp Cận Hỗ Trợ Học Tập AI Cá Nhân Hóa</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/6fee188f-4308-4720-ab4f-43ee512b0463/image3.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910361222-axiant-launches-with-innovative-process-first-methodology-to-address-automation-failures</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T22:42:00+00:00</news:publication_date>
        <news:title>Axiant Launches with Innovative Process-First Methodology to Address Automation Failures</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3251527/axiant-logo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910342560-nanobiotix-announces-protocol-amendment-to-ongoing-global-phase-3-head-and-neck-cancer-study</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:29:27+00:00</news:publication_date>
        <news:title>Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910342587-nanobiotix-annonce-un-amendement-du-protocole-de-l-tude-mondiale-de-phase-3-sur-le-cancer-de-la-t-te-et-du-cou</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:29:27+00:00</news:publication_date>
        <news:title>NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910342532-edgesource-corporation-acquires-lyteworx-automation-systems-deepening-its-defense-and-intelligence-mission-capabilities</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:28:35+00:00</news:publication_date>
        <news:title>Edgesource Corporation Acquires Lyteworx Automation Systems, Deepening Its Defense and Intelligence Mission Capabilities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ba7fdda5-6ced-4314-801e-44f9e00da542/small/edgesource-logo-pr-1200-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910342447-jiade-limited-announces-pricing-of-up-to-12-0-million-registered-direct-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:10:00+00:00</news:publication_date>
        <news:title>JIADE LIMITED Announces Pricing of up to $12.0 Million Registered Direct Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/66c132ba-862c-42c5-92fc-aab67a82bf74/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910342356-new-publication-demonstrates-tlx250-px-zircaix-potential-in-diagnosing-kidney-cancers-beyond-ccrcc</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:00:00+00:00</news:publication_date>
        <news:title>New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333422-tango-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:31:00+00:00</news:publication_date>
        <news:title>Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d6e37a27-2e33-43bb-ae05-bfb0dedbf190/small/tango-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333352-teva-to-present-at-the-bofa-securities-health-care-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Teva to Present at the BofA Securities Health Care Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333368-vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333377-cellectis-to-report-first-quarter-financial-results-on-may-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Cellectis to Report First Quarter Financial Results on May 11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333384-cellectis-publiera-ses-r-sultats-financiers-du-premier-trimestre-le-11-mai-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333396-crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333425-microvast-schedules-first-quarter-earnings-call</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Microvast Schedules First Quarter Earnings Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/df776795-0f3f-47ee-8207-63d8c61b98bb/small/microvast-tag-bluewhite-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333429-opus-genetics-announces-fda-acceptance-of-opgx-lca5-into-rare-disease-evidence-principles-rdep-program</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333432-eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333456-bioage-to-host-r-d-day-focused-on-nlrp3-inhibition-on-may-8-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>BioAge to Host R&amp;D Day Focused on NLRP3 Inhibition on May 8, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333491-cvrx-announces-first-patient-enrollment-in-benefit-hf-a-landmark-heart-failure-trial-evaluating-barostim-in-significantly-expanded-population</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333399-anaptys-to-participate-at-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:15:00+00:00</news:publication_date>
        <news:title>Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910333489-kuvi-integrates-with-kucoin-broker-pro-to-advance-agentic-finance-adoption</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:15:00+00:00</news:publication_date>
        <news:title>Kuvi Integrates with KuCoin Broker Pro to Advance Agentic Finance Adoption</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/eff106d2-82fe-40b8-a438-742d86074e01/small/555-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324529-3-e-network-technology-signs-1-3m-convertible-note-agreement-with-institutional-investor</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:10:00+00:00</news:publication_date>
        <news:title>3 E Network Technology Signs 1.3M Convertible Note Agreement with Institutional Investor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8f4e21c2-5e2c-4ce6-88ee-66c06500e891/small/22222-2026-01-14-183954-150-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324540-kyntra-bio-to-report-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Kyntra Bio to Report First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9105c1e9-d9e3-4b68-9fc8-261fed7db250/small/kyntra-bio-r-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324550-tactile-systems-technology-inc-reports-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7ecb6926-a715-4305-979c-a80795dbab83/small/tactile-medical-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324583-rumble-announces-timing-of-first-quarter-2026-earnings-release-and-conference-call</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Rumble Announces Timing of First Quarter 2026 Earnings Release and Conference Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e41a1c60-94cb-441c-8c8e-c8202cad5bce/small/image1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324622-clip-money-inc-announces-amendment-of-unsecured-convertible-notes</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Clip Money Inc. Announces Amendment of Unsecured Convertible Notes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/80569958-6412-49bc-802d-e98810b40181/small/logo-800-300dpi-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324625-everquote-announces-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>EverQuote Announces First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/86005bfc-f760-4c2f-9bfc-d896152a9bea/small/everquote-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324647-silvaco-announces-participation-at-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Silvaco Announces Participation at Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/86c898ba-7d91-45b3-9db0-edb7315ddaba/small/silvaco-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324650-capricor-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-recent-corporate-update-on-may-12</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/16ce4387-5b8f-447c-96b8-7c453633f9bf/small/getimage-48-768x274-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324654-lexicon-pharmaceuticals-announces-100-million-loan-facility-with-hercules-capital</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324720-aktis-oncology-initiates-phase-1b-clinical-trial-for-aky-2519-a-b7-h3-miniprotein-radioconjugate-in-metastatic-castration-resistant-prostate-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324766-oric-pharmaceuticals-reports-first-quarter-2026-financial-results-and-operational-updates</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/acbc0ad2-7a44-4ee7-b729-ab92d57ffafb/small/oric-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324758-ocugen-announces-private-offering-of-115-million-of-convertible-senior-notes</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:51+00:00</news:publication_date>
        <news:title>Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324495-praxis-precision-medicines-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026-and-participate-in-upcoming-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324509-fibrobiologics-reports-preclinical-data-showing-fibroblast-spheroids-may-actively-reprogram-the-burn-wound-environment-to-drive-healing-and-reduce</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324510-biodesix-announces-first-quarter-2026-results-and-highlights</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>Biodesix Announces First Quarter 2026 Results and Highlights</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324629-hemab-therapeutics-announces-closing-of-upsized-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/M2UyM2ExNWYtYTJjYi00M2RhLTkwZGEtNjZlYTUyMzI4NTI4LTEzMjE4MjEtMjAyNi0wNS0wNC1lbg==/tiny/Hemab-Therapeutics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324596-cytokinetics-to-announce-topline-results-from-acacia-hcm-the-pivotal-phase-3-clinical-trial-of-aficamten-in-patients-with-non-obstructive</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:00:00+00:00</news:publication_date>
        <news:title>Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324602-visionary-holdings-inc-announces-receipt-of-nasdaq-delisting-determination-letter-related-to-delinquent-listing-fees</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:00:00+00:00</news:publication_date>
        <news:title>Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/Mzc5NzU4NDctOGU1ZC00Y2JjLWE1YjEtMjkxMmYzYjM3M2Q3LTEzMTczMjYtMjAyNi0wNS0wNC1lbg==/tiny/Visionary-Holdings-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910324663-crn-recognizes-11-employees-at-climb-channel-solutions-on-the-2026-women-of-the-channel-list-and-names-climb-s-chief-marketing-officer-as-one-of-the</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T19:29:34+00:00</news:publication_date>
        <news:title>CRN Recognizes 11 Employees at Climb Channel Solutions on the 2026 Women of the Channel List and Names Climb’s Chief Marketing Officer as one of the 2026 Women of the Channel Power 100</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7f62397-551b-4c5f-ac67-cd3baeeb84e4/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910315198-roadzen-announces-pricing-of-8-million-registered-direct-offering-of-ordinary-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T19:27:19+00:00</news:publication_date>
        <news:title>Roadzen Announces Pricing of $8 Million Registered Direct Offering of Ordinary Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5101ee32-4aaf-4552-aa26-c4ed796caf72/small/roadzen-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910315145-liabilityscore-announces-new-platform-to-bring-credit-score-logic-to-contract-risk-built-for-small-businesses-not-lawyers</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T19:20:00+00:00</news:publication_date>
        <news:title>LiabilityScore Announces New Platform to Bring Credit-Score Logic to Contract Risk — Built for Small Businesses, Not Lawyers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3240312/Commercial-Lease-Score.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910306646-sana-commerce-appoints-brian-plackis-cheng-as-ceo</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T18:20:25+00:00</news:publication_date>
        <news:title>Sana Commerce Appoints Brian Plackis Cheng as CEO</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/ec9f9caa-d98f-47e3-acc7-b19eaab978ae/small/sana-logotype-red-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910298991-michael-haske-to-become-isolved-ceo-as-company-embarks-on-next-phase-of-ai-led-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T18:00:00+00:00</news:publication_date>
        <news:title>Michael Haske to Become isolved CEO as Company Embarks on Next Phase of AI-Led Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7803669-a575-4be5-a22a-b9982b790c1c/small/isolved-logo-color-pos-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910298983-amazon-one-medical-glp-1-program-evaluated-how-the-new-program-works-what-it-costs-and-what-cash-pay-patients-should-know-first</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:51:04+00:00</news:publication_date>
        <news:title>Amazon One Medical GLP-1 Program Evaluated: How the New Program Works, What It Costs, and What Cash-Pay Patients Should Know First</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ee6fb8bf-1ad4-4b37-8ad6-34f3692f808e/medium/direct-meds.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910291456-admaxxer-surpasses-5-000-active-brands-and-1-2-billion-in-tracked-gmv-reinforcing-its-position-as-a-leading-dtc-analytics-and-ai-ad-operations</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:05:00+00:00</news:publication_date>
        <news:title>Admaxxer Surpasses 5,000 Active Brands and $1.2 Billion in Tracked GMV, Reinforcing Its Position as a Leading DTC Analytics and AI Ad Operations Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3248977/Admaxxer-Surpasses-5%2C000-Active-Brands-and-%241.2-Billion-in-Tracked-GMV%2C-Reinforcing-Its-Position-as-a-Leading-DTC-Analytics-and-AI-Ad-Operations-Platform-Press.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910291473-eascra-biotech-welcomes-dr-anne-yau-as-life-science-research-scientist</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:04:04+00:00</news:publication_date>
        <news:title>Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1eda41c1-8c5d-43f0-9198-b0a1570f47e6/medium/dr-anne-yau.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910278459-deepinfra-closes-107m-series-b-to-power-production-scale-ai-inference</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>DeepInfra Closes $107M Series B to Power Production-Scale AI Inference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f36602ae-b2cf-4f29-be62-c811818f6e32/small/deepinfra-logo-horizontal-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910278468-samba-tv-bolsters-technical-leadership-with-promotion-of-jaya-aswani-to-cto-and-appointment-of-ramzi-nasr-as-vp-of-engineering</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>Samba TV bolsters technical leadership with promotion of Jaya Aswani to CTO and appointment of Ramzi Nasr as VP of Engineering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a74fa7-09fe-4ed7-8189-1587683af145/small/samba-tv-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910278471-carahsoft-recognized-in-2025-broadcom-partner-awards</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>Carahsoft Recognized in 2025 Broadcom Partner Awards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ee2f2b02-4089-4a15-93fa-0956daf4ad82/small/carahsoft-blue-logo-web-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910278515-asentum-announces-ase-token-presale-ahead-of-post-quantum-mainnet-release</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>Asentum Announces $ASE Token Presale Ahead of Post-quantum Mainnet Release</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ff6e601c-253e-46a5-aeb1-de722f4fdcd5/small/screenshot-2026-04-30-104146-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910278486-microcloud-hologram-inc-efficient-deterministic-quantum-state-preparation-algorithm-based-on-decision-diagrams</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:40:00+00:00</news:publication_date>
        <news:title>MicroCloud Hologram Inc. Efficient Deterministic Quantum State Preparation Algorithm Based on Decision Diagrams</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/OWYyYTNlYjctOWMzYi00ZmU4LWEyMTktOTQwOWU0MGM5Y2M1LTEzMTA4OTctMjAyNi0wNS0wNC1lbg==/tiny/MicroCloud-Hologram-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910278494-focus-school-software-celebrates-20-years-as-a-leading-national-provider-of-k-12-technology-solutions</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:34:49+00:00</news:publication_date>
        <news:title>Focus School Software Celebrates 20 Years as a Leading National Provider of K-12 Technology Solutions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/559730d4-2aa4-418f-81fa-507e7f90d91b/small/focus-logo-1200x630-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910272579-warmysender-reaches-15-000-users-reinforcing-position-as-top-instantly-alternative</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:15:00+00:00</news:publication_date>
        <news:title>WarmySender Reaches 15,000 Users, Reinforcing Position as Top Instantly Alternative</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3248932/WarmySender-Reaches-15%2C000-Users%2C-Reinforcing-Position-as-Top-Instantly-Alternative-Press.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910272589-flyguys-launches-reality-behind-the-flight-a-new-podcast-exploring-the-world-of-reality-data-capture</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:11:34+00:00</news:publication_date>
        <news:title>FlyGuys Launches “Reality: Behind the Flight,” A New Podcast Exploring the World of Reality Data Capture</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDIxMjMxODItNjljMi00ZmM3LTgyNDMtMzVlZmE5MWI0ODQxLTUwMDE2MjAxNy0yMDI2LTA1LTA0LWVu/tiny/FlyGuys-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910272515-intuitive-ai-achieves-aws-data-and-analytics-competency-as-enterprises-reassess-the-foundations-of-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:00:00+00:00</news:publication_date>
        <news:title>Intuitive.ai achieves AWS Data and Analytics Competency as Enterprises Reassess the Foundations of AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3fc27a9a-561c-455c-b3a6-6a83ba8090b8/small/intuitive-logo-secondary-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910272541-sophos-celebrates-22-leaders-named-to-2026-crn-women-of-the-channel-list</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:56:39+00:00</news:publication_date>
        <news:title>Sophos Celebrates 22 Leaders Named to 2026 CRN Women of the Channel List</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/35db908a-b7b8-4ce0-b920-69875da346ba/small/sophos-1200x628-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910266621-jama-software-launches-model-context-protocol-mcp-server</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:45:00+00:00</news:publication_date>
        <news:title>Jama Software Launches Model Context Protocol (MCP) Server</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0f19efa9-cf4d-43a0-9f83-4d48de067aec/small/jama-software-logo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910266571-flexera-channel-leaders-spotlighted-across-the-crn-2026-women-of-the-channel-list</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:30:00+00:00</news:publication_date>
        <news:title>Flexera Channel Leaders Spotlighted Across the CRN® 2026 Women of the Channel List</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/691aa193-5f37-4e50-8fec-38e34f7a5e43/small/97e88b00-acec-4133-812f-8213dba8f99b-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910262632-mmi-s-symani-surgical-system-treats-first-alzheimer-s-patient-in-groundbreaking-remind-study</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:10:00+00:00</news:publication_date>
        <news:title>MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e9325bed-8fcb-4abf-b66e-6f076014b0fb/small/mmi-logo-stacked-tagline-positive-rgb1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910262667-owlting-group-nasdaq-owls-launches-owlpay-agent-wallet-targeting-the-emerging-multi-trillion-dollar-agentic-commerce-economy</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:07:50+00:00</news:publication_date>
        <news:title>OwlTing Group (NASDAQ: OWLS) Launches OwlPay Agent Wallet, Targeting the Emerging Multi-Trillion-Dollar Agentic Commerce Economy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5a79481c-55d1-4e33-9f88-950aa88aeec5/medium/owlting-built-the-wallet-the-agentic-economy-needs-self-cust.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910262611-research-on-new-class-of-treatments-for-ovarian-cancer-receives-725-000-in-funding-from-ovarian-cancer-canada-to-become-clinical-trial-ready</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready”</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YWY2NGZiYWEtODcyZC00Y2I5LThkZGEtYmM5ZjlkYzFkNDMzLTEzMTI5NjUtMjAyNi0wNS0wNC1lbg==/tiny/Ovarian-Cancer-Canada.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910262624-inqi-launches-ai-native-property-intelligence-platform-with-new-editor-and-expanded-iq-apps</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>InQI Launches AI-Native Property Intelligence Platform with New Editor and Expanded IQ Apps</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3244005/inqi_image_2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910262626-spring-allergies-hit-lungs-hard-doctor-of-pharmacy-explains-what-actually-helps</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>Spring Allergies Hit Lungs Hard: Doctor of Pharmacy Explains What Actually Helps</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/13a92186-d8d0-4494-9e0a-5fc1d2e363ee/small/betterbrand-logo-new-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910258304-talkdesk-announces-new-integration-to-deliver-unified-healthcare-experience-and-outcomes-analytics</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:32:15+00:00</news:publication_date>
        <news:title>Talkdesk announces new integration to deliver unified healthcare experience and outcomes analytics</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b806fec8-0de9-496b-9ddc-7775b20acf14/small/talkdesk-logo-png.PNG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910258255-coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:30:00+00:00</news:publication_date>
        <news:title>Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/07437af0-8ae3-48cf-952b-18bc6b99ca7c/small/coherus-onc-logo-rgb-150-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910258274-intouch-insight-study-finds-mobile-ordering-success-hinges-on-reliability-not-speed</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:30:00+00:00</news:publication_date>
        <news:title>Intouch Insight Study Finds Mobile Ordering Success Hinges on Reliability, Not Speed</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDhhNGZhN2MtZWVhZi00MWIwLTkxZDEtNmUyMjQ1ODIxMzM0LTUwMDE1NjYxNy0yMDI2LTA1LTA0LWVu/tiny/Intouch-Insight.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910258286-alpha-tau-announces-100-local-disease-control-rate-and-favorable-safety-profile-observed-in-alpha-dart-pancreatic-cancer-trials-presented-at-ddw</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:17:21+00:00</news:publication_date>
        <news:title>Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910258285-alternative-ballistics-corporation-otcqb-albc-to-host-corporate-update-call-on-may-7-2026-at-8-30-am-et</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:15:00+00:00</news:publication_date>
        <news:title>Alternative Ballistics Corporation (OTCQB: ALBC) to Host Corporate Update Call on May 7, 2026 at 8:30 AM ET</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6f3eddb5-8d1a-420e-b07f-3e21f440c666/small/albc-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910252863-prismatic-launches-skills-for-claude-code-to-help-developers-ship-integrations-faster</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:05:00+00:00</news:publication_date>
        <news:title>Prismatic Launches Skills for Claude Code to Help Developers Ship Integrations Faster</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3ffa5f28-f782-4562-9961-b68fe61d97c2/medium/prismatic-launches-skills-for-claude-code.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910253033-greece-launches-world-s-first-national-wildfire-satellite-system-with-ororatech</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:04:00+00:00</news:publication_date>
        <news:title>Greece Launches World’s First National Wildfire Satellite System with OroraTech</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f405d4dd-2633-4e23-8086-bbaa6bf83b25/medium/ororatech-s-hellenic-fire-system.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910253114-aura-biosciences-announces-pricing-of-260-million-public-offering-of-common-stock-and-pre-funded-warrants</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:03:06+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910252843-operant-ai-launches-endpoint-protector-securing-shadow-ai-coding-agents-and-mcp-across-the-enterprise</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Operant AI Launches Endpoint Protector: Securing Shadow AI, Coding Agents, and MCP Across the Enterprise</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cf992a83-aa53-4fbe-8acd-1dbc5d0de200/small/operant-black-logo-master-png-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910252851-asus-releases-2026-future-of-small-business-report</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>ASUS Releases 2026 Future of Small Business Report</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3239907/Future-of-SMB-Report.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910252862-carnosyn-brands-expands-tribsyn-applications-across-beverage-dairy-and-medical-nutrition</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4b40dd5b-0137-41f8-83de-422e4b4f3196/small/nai-full-logo-green2-0-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910252869-oncolytics-biotech-reports-durable-responses-in-second-line-ras-mutant-mss-colorectal-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f0121259-b2be-4290-90a3-0d2c3b243aed/small/oncolytics-biotech-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910252951-turtle-beach-corporation-restructures-credit-facilities-to-enhance-capital-return-flexibility</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Turtle Beach Corporation Restructures Credit Facilities to Enhance Capital Return Flexibility</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8a9689c-6753-486d-b902-84d519018cbe/small/turtlebeachcorp-logo-stacked-blk-28-11-2023-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910252971-fate-therapeutics-announces-three-presentations-at-the-2026-asgct-annual-meeting-highlighting-off-the-shelf-car-t-cell-therapy-pipeline-for-cancer-and</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910253027-quantum-x-labs-files-u-s-patent-application-for-high-precision-quantum-atomic-clock-for-potential-use-in-the-aerospace-defense-industries</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:52:00+00:00</news:publication_date>
        <news:title>Quantum X Labs Files U.S. Patent Application for High Precision Quantum Atomic Clock for Potential Use in the Aerospace &amp; Defense Industries</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a0abc50a-ff3e-420e-9e21-807bbc6417cd/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910253043-gyre-therapeutics-completes-acquisition-of-cullgen-to-create-u-s-and-china-based-fully-integrated-biopharmaceutical-company</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:47:47+00:00</news:publication_date>
        <news:title>Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/24951768-57e9-4d7a-b969-f00258b17136/small/gyre-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910253010-polyrizon-announces-u-s-patent-expansion-for-its-intranasal-drug-delivery-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:45:00+00:00</news:publication_date>
        <news:title>Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YWIxMzIzNDgtN2UwNy00NTAyLThjZDMtZWMwNGFjZTdmNWJhLTUwMDEyOTIyMy0yMDI2LTA1LTA0LWVu/tiny/Polyrizon-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910252891-aitx-to-present-at-the-ld-micro-invitational-xvi</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:40:00+00:00</news:publication_date>
        <news:title>AITX to Present at the LD Micro Invitational XVI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/882a78f6-94c4-4a5c-a750-564a6dea2bb5/small/aitx-logo-1920x1080-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910247553-mapi-pharma-explores-u-s-aseptic-manufacturing-facility-to-support-growing-demand-for-aseptic-and-long-acting-generic-and-innovative-injectables</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a15e698a-0f26-4d44-bf6a-78b7ae34d25d/small/mapi-pharma-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910247597-abeona-therapeutics-announces-date-of-first-quarter-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Abeona Therapeutics® Announces Date of First Quarter Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910247608-satellogic-expands-global-sales-force-with-senior-defense-and-intelligence-industry-veterans</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Satellogic Expands Global Sales Force with Senior Defense and Intelligence Industry Veterans</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d2d0c386-2a99-4434-aa48-fc69a11ff8a7/small/satellogic-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910247610-fibrobiologics-announces-release-of-cywc628-drug-product-for-phase-1-2-diabetic-foot-ulcer-clinical-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910247630-fortress-biotech-to-participate-in-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d82bf2ce-81b7-4989-9e6b-08e6bb6e1f95/small/fortressbio1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910247641-service-robotics-growth-accelerates-as-global-demand-fuels-strategic-expansion</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/45ff7033-6ad2-41ba-bbd1-912eb2907b3e/small/ainewswire-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910247668-liquidia-corporation-to-report-first-quarter-2026-financial-results-on-may-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f7659070-cc55-4e68-ae70-33013e7df72c/small/liquidia-new-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910247674-newgen-provides-update-on-fiscal-year-2025-results-and-strategic-progress</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZWQwY2VjNmQtYTdlZi00YTUxLTg3NmItMmI3OWVkMTQ5MGQ4LTEyOTcwMTEtMjAyNi0wNS0wNC1lbg==/tiny/NewGenIvf-Limited.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910247689-axe-compute-inc-nasdaq-agpu-ceo-chris-miglino-to-appear-on-schwab-network-may-4-and-cheddar-may-6</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242598-candel-therapeutics-to-host-investor-conference-call-following-presentation-of-extended-data-from-phase-3-trial-of-aglatimagene-besadenovec-in</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:05:00+00:00</news:publication_date>
        <news:title>Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242367-proqr-announces-annual-general-meeting-of-shareholders-to-be-held-june-2-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242370-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/7cf77d4a-25b5-4471-a282-0334907cbfbd/small/falk-logo-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242372-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/540f0a78-db35-42ad-9e90-7b81e8ff3ad6/small/renirl-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242373-cptx-to-present-preclinical-proof-of-principle-of-its-dna-based-in-vivo-car-t-platform-at-asgct-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/b3ec9ca7-8866-466a-9d91-09342002e341/small/cptx-logo-high-res-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242419-evaxion-to-announce-business-update-and-first-quarter-2026-financial-results-on-may-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242435-recludix-pharma-announces-upcoming-oral-presentations-on-preclinical-data-for-oral-stat6-inhibitor-rex-8756-and-topical-stat-1-3-inhibitors-at-the</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NDM5ZGUzYTItNGI0Zi00N2Y3LWE3Y2QtZmViNDYyN2I1ZWRjLTEyMzYyMjItMjAyNi0wNS0wNC1lbg==/tiny/Recludix-Pharma-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242438-rhythm-pharmaceuticals-announces-new-data-presentations-in-acquired-hypothalamic-obesity-at-pediatric-endocrine-society</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242442-spur-therapeutics-presents-clinical-insights-on-bone-disease-impact-of-flt201-in-adults-with-gaucher-disease-type-1</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/195ccecc-f977-4fb5-ba01-43af7ec47589/small/spur-therapeutics-black-wopacity-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242445-zoom-recognizes-the-rise-of-ai-powered-businesses-of-one-with-inaugural-solopreneur-50</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Zoom Recognizes the Rise of AI-Powered Businesses of One with Inaugural Solopreneur 50</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a5e6f52-9a8e-432b-84cc-7dfb0e6623e2/small/logo-zm-app-icon-container-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242449-kyverna-therapeutics-appoints-nadia-dac-seasoned-commercial-leader-in-neurology-and-rare-disease-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242457-4dmt-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>4DMT to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242470-valitor-presents-preclinical-data-demonstrating-superior-durability-with-six-month-treatment-protocol-of-vltr-559-to-treat-wet-amd</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242472-applied-digital-announces-300-million-senior-secured-bridge-facility</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Applied Digital Announces $300 Million Senior Secured Bridge Facility</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a09f7f80-1e66-44ed-b53a-6007ec7be92a/small/applied-digital-logo-horizontal-black-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242494-tessell-appoints-matt-mcdonough-and-jeffrey-carter-to-executive-team-to-accelerate-enterprise-database-modernization</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Tessell Appoints Matt McDonough and Jeffrey Carter to Executive Team to Accelerate Enterprise Database Modernization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/503f121a-0162-4ce3-84b3-ae5e04dc98e5/medium/jeff-carter-chief-strategy-officer.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242516-kaltura-open-sources-suite-of-ai-agent-skills-enabling-any-ai-agent-to-build-intelligent-rich-media-digital-experiences</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Kaltura Open-Sources Suite of AI Agent Skills, Enabling Any AI Agent to Build Intelligent Rich-Media Digital Experiences  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/584e487b-dd12-4a20-a5b1-c42f4579d369/small/kaltura-logo-vertical-colorsun-blacktext-small.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242538-lifeward-announces-new-rewalk-data-presented-at-asia-2026-conference-demonstrating-a-comprehensive-longitudinal-safety-analysis-for-a-powered</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242564-atsena-presents-positive-interim-six-month-results-from-part-b-of-phase-1-2-3-lighthouse-trial-evaluating-atsn-201-in-patients-with-x-linked</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242567-rocket-doctor-ai-reports-strong-2025-results-validating-physician-led-model-with-key-u-s-payer-contracts-and-ai-innovation</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI Innovation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/648c6dd6-c4c0-4ceb-9a78-26fecd4678a7/small/rocket-doctor-logo-250821-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242574-after-successful-fda-meeting-clene-filing-accelerated-approval-nda-for-als</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242582-legend-biotech-expands-scientific-advisory-expertise-to-inform-future-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242595-swarmer-partners-with-rakuten-to-enter-japan-s-advanced-autonomy-market</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Swarmer Partners With Rakuten to Enter Japan&#39;s Advanced Autonomy Market</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/46b28796-9654-4d2b-89db-91de399ba76a/small/swarmer-logo-dark-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910242608-ruanyun-edai-technology-s-saudi-rhq-signs-mou-with-wadi-makkah-a-subsidiary-of-umm-al-qura-university</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Ruanyun Edai Technology’s Saudi RHQ Signs MOU with Wadi Makkah, A Subsidiary of Umm Al-Qura University</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0b7372f3-6354-4bba-acc5-bb10b1de4c3a/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910237832-macrogenics-and-sagard-healthcare-partners-enter-into-expanded-zynyz-royalty-purchase-agreement</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910237841-bridgebio-to-present-new-acoramidis-data-on-disease-progression-biomarkers-and-clinical-outcomes-at-esc-heart-failure-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910237849-kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910237860-palvella-therapeutics-announces-first-patients-dosed-in-phase-2-lotu-trial-of-fast-track-designated-qtorin-rapamycin-for-clinically-significant</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910237878-inflarx-reports-favorable-reactive-metabolite-profile-for-izicopan-in-human-liver-microsomes</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910237897-earthdaily-advancing-daily-global-measurement-of-planetary-change-with-six-satellites-launched</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>EarthDaily Advancing Daily Global Measurement of Planetary Change with Six Satellites Launched</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/63895f31-922c-451d-894e-110f2f640ad9/medium/earthdaily-satellite-deploys.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910237911-windward-bio-announces-165m-crossover-financing-to-advance-pipeline-of-long-acting-immunology-therapies-with-best-in-disease-potential</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/Nzk5NDkzNGQtNWZiNi00MGZkLTg2ZTAtYzViNDkwNTJjOTVmLTUwMDEzMTYxMS0yMDI2LTA1LTA0LWVu/tiny/Windward-Bio.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910237925-micropolis-robotics-unveils-new-next-generation-high-endurance-robot-at-the-make-it-in-the-emirates-2026-industry-exhibition</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:29:19+00:00</news:publication_date>
        <news:title>Micropolis Robotics Unveils New, Next-Generation, High-Endurance Robot at the Make it in the Emirates 2026 Industry Exhibition</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ffdb8f0a-5da0-4cdc-9a97-852140e69d8b/medium/m1-5.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910237843-cartesian-therapeutics-announces-new-employment-inducement-grants</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>Cartesian Therapeutics Announces New Employment Inducement Grants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910237845-nextcure-and-simcere-zaiming-initiate-dose-optimization-for-sim0505-cdh6-adc-in-gynecologic-cancers</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910237870-kraig-biocraft-laboratories-launches-april-may-production-cycle-following-record-spider-silk-output</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3cf5ab91-0822-460b-bb13-17447941c84a/small/kblb-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233519-ardena-strengthens-executive-team-to-drive-its-next-phase-of-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Ardena Strengthens Executive Team to Drive its Next Phase of Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/eddef504-18ee-4f10-8442-9e61ef77e262/medium/ardena-appoints-cfo-and-cco.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233520-indivior-announces-175-million-accelerated-share-repurchase</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Indivior Announces $175 Million Accelerated Share Repurchase</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233589-advanced-technology-recycling-atr-announces-that-they-are-now-offering-wholesale-electronics-to-the-general-public-through-their-online-auction-site</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Advanced Technology Recycling (ATR) Announces That They Are Now Offering Wholesale Electronics to the General Public Through Their Online Auction Site</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/437d4f24-24b9-4cd4-961b-ea5dd0ab80ce/small/atr-logo-with-registered-trademark-badge-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233590-biocryst-announces-european-licensing-agreement-with-irish-affiliate-of-neopharmed-gentili-for-navenibart-in-hereditary-angioedema</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233621-tenax-therapeutics-appoints-timothy-healey-mba-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233629-krystal-biotech-announces-first-quarter-2026-financial-and-operating-results</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Krystal Biotech Announces First Quarter 2026 Financial and Operating Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/94ec1f39-c0eb-4e65-9d7e-250519ef03f4/small/krys-logo-nobackground-with-registered-symbol-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233642-10-barrel-brewing-launches-clean-slate-and-salty-sips-expanding-rtd-line-with-functional-n-a-and-low-sugar-cocktails</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5e71b27b-1cc8-4780-8689-8d8d6ae86236/medium/clean-slate-and-salty-sips.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233645-seres-therapeutics-presents-preclinical-data-at-digestive-disease-week-ddw-2026-supporting-ser-603-a-next-generation-cultivated-live-biotherapeutic</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233649-centrum-launches-newly-reformulated-adults-50-complete-multivitamin-with-clinically-shown-cognitive-benefits</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/395df94a-8079-4f58-9b54-df434e56ec33/medium/centrum-adults-50-complete-multivitamin.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233653-centrum-lance-sa-multivitamine-compl-te-adultes-50-nouvellement-reformul-e-avec-des-bienfaits-cognitifs-d-montr-s-cliniquement</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Centrum lance sa multivitamine complète Adultes 50+ nouvellement reformulée avec des bienfaits cognitifs démontrés cliniquement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/abbbfaf3-e52b-413c-9ded-52f74cf50911/medium/centrum-multivitamine-complete-pour-adultes-50.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233661-genyro-announces-new-paper-demonstrating-how-sidewinder-technology-democratizes-dna-construction-at-scale-and-facilitates-ai-driven-protein-design</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Genyro Announces New Paper Demonstrating How Sidewinder Technology Democratizes DNA Construction at Scale and Facilitates AI-Driven Protein Design</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/346f123b-cc5d-4de0-a31f-9c4f1315c070/medium/genyro-co-founders.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233678-seer-announces-appointment-of-anthony-bazarko-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ecdddbc3-8a58-4cba-a4a1-33971e79339a/medium/anthony-bazarko.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233683-istios-health-partners-with-care-id-to-expand-national-infectious-disease-clinical-research-network</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Istios Health Partners with CARE-ID to Expand National Infectious Disease Clinical Research Network</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MTI0OGVmYTMtNmZkNC00ODA4LWJlNzUtNTYxODJlODcxNDBmLTEzMTYxMjEtMjAyNi0wNS0wNC1lbg==/tiny/Istios-Health.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233687-adma-biologics-announces-fda-approval-to-expand-the-label-for-asceniv-to-include-pediatric-immune-compromised-patients-two-years-of-age-and-older</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233694-meet-sprysite-the-website-builder-and-marketing-platform-redefining-small-business-websites</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Meet SprySite: The Website Builder and Marketing Platform Redefining Small Business Websites</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3244560/sprypro.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233575-descartes-sets-date-to-announce-first-quarter-fiscal-2027-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:45:00+00:00</news:publication_date>
        <news:title>Descartes Sets Date to Announce First Quarter Fiscal 2027 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2fab20c0-6dcb-4891-840a-37d0d482f33a/small/descartes-systems-group-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910233704-cabaletta-bio-announces-pricing-of-150-million-underwritten-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:35:54+00:00</news:publication_date>
        <news:title>Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/44175396-6bbb-435f-b037-54a4052160d4/small/cabaletta-bio-registered-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910224348-aura-biosciences-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:03:00+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910224335-aura-biosciences-announces-ceo-transition-as-company-advances-phase-3-compass-trial-toward-enrollment-completion</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:01:00+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910224345-scilex-holding-company-announces-its-board-of-directors-approved-may-26-2026-as-the-payment-date-of-the-previously-announced-dividend-of-dream-bowl</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:00:00+00:00</news:publication_date>
        <news:title>Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the…</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910216010-what-is-the-best-internet-solution-for-business-travel-why-holafly-for-business-is-becoming-the-preferred-choice-for-global-companies</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:54:07+00:00</news:publication_date>
        <news:title>What is the best internet solution for business travel? Why Holafly for Business is becoming the preferred choice for global companies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/ff9372ad-41f6-4acc-8266-5578d80cc425/medium/why-holafly-for-business-is-becoming-the-preferred-choice-fo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910206820-virtune-ab-publ-virtune-hat-die-monatliche-neugewichtung-f-r-april-2026-des-virtune-crypto-altcoin-index-etps-durchgef-hrt</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:06:34+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) („Virtune“) hat die monatliche Neugewichtung für April 2026 des Virtune Crypto Altcoin Index ETPs durchgeführt</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910206825-virtune-ab-publ-virtune-has-completed-the-monthly-rebalancing-for-april-2026-of-its-virtune-crypto-altcoin-index-etp</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:06:34+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) (&quot;Virtune&quot;) has completed the monthly rebalancing for April 2026 of its Virtune Crypto Altcoin Index ETP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910206829-virtune-ab-publ-virtune-har-genomf-rt-den-m-natliga-rebalanseringen-f-r-april-2026-av-virtune-crypto-altcoin-index-etp</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:06:34+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) (&quot;Virtune&quot;) har genomfört den månatliga rebalanseringen för april 2026 av Virtune Crypto Altcoin Index ETP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910188220-proper-hills-launches-ultra-slim-alloy-magnetic-power-bank-for-design-conscious-consumers</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T05:30:58+00:00</news:publication_date>
        <news:title>Proper Hills Launches Ultra-Slim Alloy Magnetic Power Bank for Design-Conscious Consumers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/382df764-328b-4049-8389-ac0950f52367/medium/proper-hills-just-made-a-power-bank-thinner-than-a-pencil-th.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910177238-unbounded-vision-dreame-window-cleaning-robot-debuts-in-north-america-redefining-vertical-cleaning-with-precision-technology</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T04:17:56+00:00</news:publication_date>
        <news:title>Unbounded Vision: Dreame Window Cleaning Robot Debuts in North America, Redefining Vertical Cleaning with Precision Technology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/d9c436d7-c9c5-46ff-8495-5a11d321f6a3/3-5.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910162333-lakefusion-raises-7-5m-seed-financing-to-redefine-master-data-management-mdm-natively-on-databricks</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T02:02:10+00:00</news:publication_date>
        <news:title>LakeFusion Raises $7.5M Seed Financing to Redefine Master Data Management (MDM) Natively on Databricks</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/78680f0e-2aae-4cb5-8bf0-8e3d8bb6b896/medium/lakefusion-raises-7-5m-seed-financing-to-redefine-master-dat.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910150844-novelty-nobility-taps-agc-biologics-to-further-develop-bispecific-drug-candidate</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cecf4f80-22df-4bbf-b0a7-f50b9acf9495/medium/agc-biologics-and-novelty-nobility-representatives-meet.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910150881-agc</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>ノベルティ・ノビリティ、AGCバイオロジクスと提携し、二重特異性抗体候補薬の開発を推進</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1qYQ==/tiny/AGC-Biologics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910150885-novelty-nobility-agc-biologics</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>노벨티 노빌리티 (Novelty Nobility), 이중특이성 항체 개발 위해 AGC Biologics와 협력 확대</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1rbw==/tiny/AGC-Biologics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910145359-crypto-news-today-alphapepe-presale-ai-dex-hits-final-testing-whilst-bitcoin-price-prediction-points-to-120-000</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T23:30:00+00:00</news:publication_date>
        <news:title>Crypto News Today: AlphaPepe Presale AI DEX Hits Final Testing Whilst Bitcoin Price Prediction Points to $120,000</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2c8b0156-2a64-4138-b75f-f7aaa8bdfd49/medium/alphapepe.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910130237-neuro-salt-under-investigation-full-pink-salt-trick-consumer-report-reveals-shocking-hidden-risks</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T20:52:12+00:00</news:publication_date>
        <news:title>Neuro Salt Under Investigation: Full &quot;Pink Salt Trick&quot; Consumer Report Reveals Shocking Hidden Risks</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5b7201ce-5f4e-4a97-9fe8-95a77e66b2b7/medium/neuro-salt.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910111834-luma-glasses-unveiled-does-lumaglasses-smart-ai-glasses-really-works-read-luma-glasses-consumer-report</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T18:16:40+00:00</news:publication_date>
        <news:title>Luma Glasses Unveiled: Does LumaGlasses Smart AI Glasses Really Works? Read Luma Glasses Consumer Report! </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c2a2f020-e4e2-491b-aa89-89d3efaa0309/medium/luma-glasses.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910074985-russian-oil-asset-fund-launches-public-website-and-solana-token-information-hub-for-roaf</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T13:00:00+00:00</news:publication_date>
        <news:title>Russian Oil Asset Fund Launches Public Website and Solana Token Information Hub for $ROAF</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a1ac6677-6dcc-4559-8941-b2ce8d5537ad/small/555-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.arubasciencewire.com/article/910068316-bsstrategy-introduces-ai-powered-trading-workspace-for-strategy-development-and-portfolio-management</loc>
      <news:news>
        <news:publication>
          <news:name>Aruba Science Wire</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T12:00:00+00:00</news:publication_date>
        <news:title>BsStrategy Introduces AI-Powered Trading Workspace for Strategy Development and Portfolio Management</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/29228b48-2078-4e24-8423-55e6f010abde/medium/bsstrategy-logo.png</image:loc>
        </image:image>
    </url>
</urlset>
